000 02280nam  2200433zi 4500
0019.931438
003CaOODSP
00520240221071858
006m     o  d f      
007cr mn|||||||||
008231213s2023    onc     obs  f000 0 eng d
020 |a9780660693064
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
045 |ay2y2
0861 |aPS82-4/23-32E-PDF
1001 |aFiloso, Daniella, |eauthor.
24510|aPrevalence of SARS-CoV-2 antibodies among federally incarcerated women / |cprepared by Daniella Filoso & Kayla Wanamaker.
264 1|a[Ottawa] : |bCorrectional Service Canada = Service correctionnel Canada, |c2023.
300 |a1 online resource (1 page).
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
4901 |aResearch in brief ; |vRIB-23-32
500 |aIssued also in French under title: Prévalence d'anticorps contre le SRAS-CoV-2 chez les femmes incarcérées dans les établissements fédéraux.
504 |aIncludes bibliographical references.
520 |a"In collaboration with Public Health Agency of Canada (PHAC) and the University of Ottawa, Correctional Service Canada (CSC) conducted the 2022 National Health Survey. One of the study objectives was to determine the prevalence of SARS-CoV-2 antibodies and whether they are derived from immunization or infection among federally incarcerated women."
650 0|aWomen prisoners|xDiseases|zCanada|vStatistics.
650 0|aCOVID-19 (Disease)|zCanada|vStatistics.
650 0|aCOVID-19 (Disease)|xVaccination|zCanada|vStatistics.
650 0|aViral antibodies.
655 7|aStatistics|2lcgft
7102 |aCorrectional Service Canada, |eissuing body.
77508|tPrévalence d'anticorps contre le SRAS-CoV-2 chez les femmes incarcérées dans les établissements fédéraux / |w(CaOODSP)9.931440
830#0|aResearch in brief (Correctional Service Canada)|vRIB-23-32.|w(CaOODSP)9.805030
85640|qPDF|s210 KB|uhttps://publications.gc.ca/collections/collection_2024/scc-csc/PS82-4-23-32-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/correctional-service/corporate/library/research/research-brief/23-32.html